Lawrence Livermore National Laboratory   Report issue

Government Phase 1
Founded: Livermore CA United States (1952)

Organization Overview

First Clinical Trial
2010
NCT01261299
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Lawrence Livermore National Laboratory

Active Ingredients

Drugs in Phase 1 Trials (3)

benzo[a]pyrene (3 trials)

carboplatin (paraplatin) (1 trial)

phenanthrene (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma, Non-Small-Cell Lung (Phase 1)

Neoplasms (Phase 1)

Urinary Bladder Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 4
  • # of Trial APIs: 3